These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
187 related articles for article (PubMed ID: 37874481)
1. Classic Famous Prescription Kai-Xin-San Ameliorates Alzheimer's Disease via the Wnt/β-Catenin Signaling Pathway. Shan X; Lv S; Huang P; Zhang W; Jin C; Liu Y; Li Y; Jia Y; Chu X; Peng C; Zhang C Mol Neurobiol; 2024 Apr; 61(4):2297-2312. PubMed ID: 37874481 [TBL] [Abstract][Full Text] [Related]
2. Kai-Xin-San Improves Cognitive Impairment via Wnt/β-Catenin and IRE1/XBP1s Signalings in APP/PS1 Mice. Xu YM; Lu FM; Xu HC; Zhang J; Hei SY; Qiu YH; Cai YF; Zhang SJ; Zhao M Rejuvenation Res; 2023 Jun; 26(3):105-115. PubMed ID: 37073462 [TBL] [Abstract][Full Text] [Related]
3. Kai-Xin-San ameliorates Alzheimer's disease-related neuropathology and cognitive impairment in APP/PS1 mice via the mitochondrial autophagy-NLRP3 inflammasome pathway. Shan X; Tao W; Li J; Tao W; Li D; Zhou L; Yang X; Dong C; Huang S; Chu X; Zhang C J Ethnopharmacol; 2024 Jul; 329():118145. PubMed ID: 38582153 [TBL] [Abstract][Full Text] [Related]
4. Kai-Xin-San, a standardized traditional Chinese medicine formula, up-regulates the expressions of synaptic proteins on hippocampus of chronic mild stress induced depressive rats and primary cultured rat hippocampal neuron. Zhu Y; Duan X; Cheng X; Cheng X; Li X; Zhang L; Liu P; Su S; Duan JA; Dong TT; Tsim KW; Huang F J Ethnopharmacol; 2016 Dec; 193():423-432. PubMed ID: 27660009 [TBL] [Abstract][Full Text] [Related]
5. Metabolomics approach to explore the effects of Kai-Xin-San on Alzheimer's disease using UPLC/ESI-Q-TOF mass spectrometry. Chu H; Zhang A; Han Y; Lu S; Kong L; Han J; Liu Z; Sun H; Wang X J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Mar; 1015-1016():50-61. PubMed ID: 26896572 [TBL] [Abstract][Full Text] [Related]
6. Kai-xin-san improves cognitive impairment in D-gal and Aβ Wang H; Zhou L; Zheng Q; Song Y; Huang W; Yang L; Xiong Y; Cai Z; Chen Y; Yuan J J Ethnopharmacol; 2024 Jul; 329():118161. PubMed ID: 38599474 [TBL] [Abstract][Full Text] [Related]
7. Therapeutic Mechanism of Kai Xin San on Alzheimer's Disease Based on Network Pharmacology and Experimental Validation. Wang K; Yang R; Chen TT; Qin MR; Wang P; Kong MW Chin J Integr Med; 2023 May; 29(5):413-423. PubMed ID: 36474082 [TBL] [Abstract][Full Text] [Related]
8. Kai-xin-san, a chinese herbal decoction containing ginseng radix et rhizoma, polygalae radix, acori tatarinowii rhizoma, and poria, stimulates the expression and secretion of neurotrophic factors in cultured astrocytes. Zhu KY; Xu SL; Choi RC; Yan AL; Dong TT; Tsim KW Evid Based Complement Alternat Med; 2013; 2013():731385. PubMed ID: 24222781 [TBL] [Abstract][Full Text] [Related]
9. Neuroprotective mechanism of Wang N; Jia YM; Zhang B; Xue D; Reeju M; Li Y; Huang SM; Liu XW Neural Regen Res; 2017 Apr; 12(4):654-659. PubMed ID: 28553348 [No Abstract] [Full Text] [Related]
10. Ginsenoside Rg1 improves Alzheimer's disease by regulating oxidative stress, apoptosis, and neuroinflammation through Wnt/GSK-3β/β-catenin signaling pathway. Yang Y; Wang L; Zhang C; Guo Y; Li J; Wu C; Jiao J; Zheng H Chem Biol Drug Des; 2022 Jun; 99(6):884-896. PubMed ID: 35313087 [TBL] [Abstract][Full Text] [Related]
11. The memory enhancement effect of Kai Xin San on cognitive deficit induced by simulated weightlessness in rats. Qiong W; Yong-Liang Z; Ying-Hui L; Shan-Guang C; Jiang-Hui G; Yi-Xi C; Ning J; Xin-Min L J Ethnopharmacol; 2016 Jul; 187():9-16. PubMed ID: 27103112 [TBL] [Abstract][Full Text] [Related]
12. Active components, derived from Kai-xin-san, a herbal formula, increase the expressions of neurotrophic factor NGF and BDNF on mouse astrocyte primary cultures via cAMP-dependent signaling pathway. Cao C; Xiao J; Liu M; Ge Z; Huang R; Qi M; Zhu H; Zhu Y; Duan JA J Ethnopharmacol; 2018 Oct; 224():554-562. PubMed ID: 29890314 [TBL] [Abstract][Full Text] [Related]
13. [Dexmedetomidine-mediated Wnt Pathway Inhibits Sevoflurane-induced Cognitive Impairment in Neonatal Rats]. Yang Y; Yang L; Wu Y; Yuan J Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2021 Apr; 43(2):235-246. PubMed ID: 33966704 [TBL] [Abstract][Full Text] [Related]
14. Global identification and determination of the major constituents in Kai-Xin-San by ultra-performance liquid chromatography-quadrupole-Orbitrap mass spectrometry and gas chromatography-mass spectrometry. Lin R; Yin J; Wu M; Ding H; Han L; Yang W; Song X; Bie S; Wang C; He Y; Yu H; Li Z J Pharm Biomed Anal; 2021 Nov; 206():114385. PubMed ID: 34597841 [TBL] [Abstract][Full Text] [Related]
15. Xu YM; Wang XC; Xu TT; Li HY; Hei SY; Luo NC; Wang H; Zhao W; Fang SH; Chen YB; Guan L; Fang YQ; Zhang SJ; Wang Q; Liang WX Neural Regen Res; 2019 May; 14(5):794-804. PubMed ID: 30688265 [TBL] [Abstract][Full Text] [Related]
16. Classic Prescription, Kai-Xin-San, Ameliorates Alzheimer's Disease as an Effective Multitarget Treatment: From Neurotransmitter to Protein Signaling Pathway. Guo S; Wang J; Xu H; Rong W; Gao C; Yuan Z; Xie F; Bi K; Zhang Z; Li Q Oxid Med Cell Longev; 2019; 2019():9096409. PubMed ID: 31354916 [TBL] [Abstract][Full Text] [Related]
17. Chinese Medicine Formula Kai-Xin-San Ameliorates Neuronal Inflammation of CUMS-Induced Depression-like Mice and Reduces the Expressions of Inflammatory Factors via Inhibiting TLR4/IKK/NF-κB Pathways on BV2 Cells. Qu S; Liu M; Cao C; Wei C; Meng XE; Lou Q; Wang B; Li X; She Y; Wang Q; Song Z; Han Z; Zhu Y; Huang F; Duan JA Front Pharmacol; 2021; 12():626949. PubMed ID: 33790789 [TBL] [Abstract][Full Text] [Related]
18. Kai-Xin-San Inhibits Tau Pathology and Neuronal Apoptosis in Aged SAMP8 Mice. Jiao YN; Zhang JS; Qiao WJ; Tian SY; Wang YB; Wang CY; Zhang YH; Zhang Q; Li W; Min DY; Wang ZY Mol Neurobiol; 2022 May; 59(5):3294-3309. PubMed ID: 35303280 [TBL] [Abstract][Full Text] [Related]
19. Rapid discovery of quality-markers from Kaixin San using chinmedomics analysis approach. Wang XJ; Zhang AH; Kong L; Yu JB; Gao HL; Liu ZD; Sun H Phytomedicine; 2019 Feb; 54():371-381. PubMed ID: 30322673 [TBL] [Abstract][Full Text] [Related]
20. Systems Pharmacology Approach to Investigate the Mechanism of Kai-Xin-San in Alzheimer's Disease. Luo Y; Li D; Liao Y; Cai C; Wu Q; Ke H; Liu X; Li H; Hong H; Xu Y; Wang Q; Fang J; Fang S Front Pharmacol; 2020; 11():381. PubMed ID: 32317964 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]